Matthew Ros

Matthew E.
Ros is currently an Independent Director at Cogent Biosciences, Inc. since 2019.
Formerly, served as Chief Executive Officer & Director at Fore Biotherapeutics, Inc. from 2022 to 2023.
Worked at Bristol Myers Squibb Co. as Senior Director from 1990 to 2007.
Held the position of Senior Vice President-Commercial Operations at ARIAD Pharmaceuticals, Inc. from 2009 to 2010.
Was Vice President & Head-Franchise at Genzyme Corp.
from 2012 to 2014.
Served as Associate Vice President at Sanofi from 2010 to 2012 and later as COO, VP & Global Head-Oncology Business Unit at Sanofi from 2014 to 2016.
Held the role of Chief Financial Officer at Epizyme, Inc. in 2021.
Held a trustee position at Cancer Care, Inc. Served as Chief Operating Officer at Verastem, Inc. in 2025.
Education includes an undergraduate degree from The State University of New York, conferred in 1988.